Clinical Results
900+ patients evaluated across multiple cancer types
Overall Performance
Sensitivity
91%-100%
Specificity
85%-100%
Results published in peer-reviewed journals across multiple medical specialties.
Clinical Trials by Indication
Request Detailed Clinical Data
For specific clinical findings, trial protocols, or publication references, please contact NovaScan directly.
Contact Us